Pharma Markets

Europe Pompe’s Disease Market and Competitive Landscape

By Fore Pharma | Published Date: June 3, 2020 | On-Demand Data

The latest research from Fore Pharma, Europe Pompe’s Disease Market and Competitive Landscape – 2020, provides comprehensive insights into Pompe’s Disease pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecast Pompe’s Disease market size and drug sales. It also provides insights into Pompe’s Disease epidemiology and late stage pipeline.

This research covers the following – Pompe’s Disease treatment options, Pompe’s Disease late stage clinical trials pipeline, Pompe’s Disease prevalence by countries, Pompe’s Disease market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:

– Countries: Germany, France, Italy, Spain, UK, Europe
– Pompe’s Disease pipeline: Find out drugs in clinical trials for Pompe’s Disease by development phase 3, phase 2, and phase 1, by pharmacological class and company
– Pompe’s Disease epidemiology: Find out number of patients diagnosed (prevalence) with Pompe’s Disease by countries
– Pompe’s Disease drugs: Identify key drugs marketed and prescribed for Pompe’s Disease by countries, including trade name, molecule name, and company
– Pompe’s Disease drugs sales: Find out the sales value for Pompe’s Disease drugs by countries
– Pompe’s Disease market valuations: Find out the market size for Pompe’s Disease drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2025
– Pompe’s Disease drugs market share: Find out the market shares for key drugs by countries

Benefits of this Research: The research helps executives to

– Evaluate commercial market opportunities for Pompe’s Disease drugs
– Synthesize insights for business development & licensing
– Track market size, competitor drug sales, market shares in Pompe’s Disease market
– Develop in-depth knowledge of competition and markets
– Analyze Pompe’s Disease drug sales data to update your brand planning trackers
– Develop tactics and strategies to take advantage of opportunities in the market
– Track Market Events and Trends and analyze key events in Pompe’s Disease market
– Develop forecast models, healthcare frameworks, or economic models
– Answer key business questions; supports decision making in R&D to long term marketing strategies

Table of Contents


1. Pompe’s Disease Treatment Options
2. Pompe’s Disease Pipeline Insights
2.1. Pompe’s Disease Phase 3 Clinical Trials
2.2. Pompe’s Disease Phase 2 Clinical Trials
2.3. Pompe’s Disease Phase 1 Clinical Trials
3. Pompe’s Disease Epidemiology Analysis by Countries
4. Germany Pompe’s Disease Market Insights
4.1. Marketed Drugs for Pompe’s Disease in Germany
4.2. Germany Pompe’s Disease Market Size & Forecast
4.3. Germany Pompe’s Disease Drugs Sales Forecast
4.4. Germany Pompe’s Disease Market Share Analysis
5. France Pompe’s Disease Market Insights
5.1. Marketed Drugs for Pompe’s Disease in France
5.2. France Pompe’s Disease Market Size & Forecast
5.3. France Pompe’s Disease Product Sales Forecast
5.4. France Pompe’s Disease Market Share Analysis
6. Italy Pompe’s Disease Market Insights
6.1. Marketed Drugs for Pompe’s Disease in Italy
6.2. Italy Pompe’s Disease Market Size & Forecast
6.3. Italy Pompe’s Disease Product Sales Forecast
6.4. Italy Pompe’s Disease Market Share Analysis
7. Spain Pompe’s Disease Market Insights
7.1. Marketed Drugs for Pompe’s Disease in Spain
7.2. Spain Pompe’s Disease Market Size & Forecast
7.3. Spain Pompe’s Disease Product Sales Forecast
7.4. Spain Pompe’s Disease Market Share Analysis
8. UK Pompe’s Disease Market Insights
8.1. Marketed Drugs for Pompe’s Disease in UK
8.2. UK Pompe’s Disease Market Size & Forecast
8.3. UK Pompe’s Disease Product Sales Forecast
8.4. UK Pompe’s Disease Market Share Analysis
9. Europe Pompe’s Disease Market Insights
9.1. Europe Pompe’s Disease Market Size & Forecast
9.2. Europe Pompe’s Disease Product Sales Forecast
9.3. Europe Pompe’s Disease Market Share Analysis
10. Research Methodology

List of Tables


1: Pompe’s Disease Phase 3 Clinical Trials, Global, 2020
2: Pompe’s Disease Phase 2 Clinical Trials, Global, 2020
3: Pompe’s Disease Phase 1 Clinical Trials, Global, 2020
4: Pompe’s Disease Prevalence by Countries, 2016 – 2025
5: Marketed Drugs for Pompe’s Disease in Germany, 2019
6: Germany Pompe’s Disease Market Size & Forecast ($mn), 2016 – 2025
7: Germany Pompe’s Disease Product Sales ($mn), 2016 – 2025
8: Germany Pompe’s Disease Market Events and Trends, 2016 – 2025
9: Marketed Drugs for Pompe’s Disease in France, 2019
10: France Pompe’s Disease Market Size & Forecast ($mn), 2016 – 2025
11: France Pompe’s Disease Product Sales ($mn), 2016 – 2025
12: France Pompe’s Disease Market Events and Trends, 2016 – 2025
13: Marketed Drugs for Pompe’s Disease in Italy, 2019
14: Italy Pompe’s Disease Market Size & Forecast ($mn), 2016 – 2025
15: Italy Pompe’s Disease Product Sales ($mn), 2016 – 2025
16: Italy Pompe’s Disease Market Events and Trends, 2016 – 2025
17: Marketed Drugs for Pompe’s Disease in Spain, 2019
18: Spain Pompe’s Disease Market Size & Forecast ($mn), 2016 – 2025
19: Spain Pompe’s Disease Product Sales ($mn), 2016 – 2025
20: Spain Pompe’s Disease Market Events and Trends, 2016 – 2025
21: Marketed Drugs for Pompe’s Disease in UK, 2019
22: UK Pompe’s Disease Market Size & Forecast ($mn), 2016 – 2025
23: UK Pompe’s Disease Product Sales ($mn), 2016 – 2025
24: UK Pompe’s Disease Market Events and Trends, 2016 – 2025
25: Europe Pompe’s Disease Market Size & Forecast ($mn), 2016 – 2025
26: Europe Pompe’s Disease Product Sales ($mn), 2016 – 2025

List of Figures


1: Pompe’s Disease Pipeline by Phase (%), Global, 2020
2: Pompe’s Disease Prevalence by Countries, 2016 – 2025
3: Germany Pompe’s Disease Market Size ($mn), 2016 – 2025
4: Germany Pompe’s Disease Product Sales ($mn), 2016 – 2025
5: Germany Pompe’s Disease Market Share by Drugs (%), 2019
6: Germany Pompe’s Disease Market – Future Market Share (%), 2025
7: France Pompe’s Disease Market Size ($mn), 2016 – 2025
8: France Pompe’s Disease Product Sales ($mn), 2016 – 2025
9: France Pompe’s Disease Market Share by Drugs (%), 2019
10: France Pompe’s Disease Market – Future Market Share (%), 2025
11: Italy Pompe’s Disease Market Size ($mn), 2016 – 2025
12: Italy Pompe’s Disease Product Sales ($mn), 2016 – 2025
13: Italy Pompe’s Disease Market Share by Drugs (%), 2019
14: Italy Pompe’s Disease Market – Future Market Share (%), 2025
15: Spain Pompe’s Disease Market Size ($mn), 2016 – 2025
16: Spain Pompe’s Disease Product Sales ($mn), 2016 – 2025
17: Spain Pompe’s Disease Market Share by Drugs (%), 2019
18: Spain Pompe’s Disease Market – Future Market Share (%), 2025
19: UK Pompe’s Disease Market Size ($mn), 2016 – 2025
20: UK Pompe’s Disease Product Sales ($mn), 2016 – 2025
21: UK Pompe’s Disease Market Share by Drugs (%), 2019
22: UK Pompe’s Disease Market – Future Market Share (%), 2025
23: Europe Pompe’s Disease Market Size ($mn), 2016 – 2025
24: Europe Pompe’s Disease Product Sales ($mn), 2016 – 2025
25: Europe Pompe’s Disease Market Share by Drugs (%), 2019
26: Europe Pompe’s Disease Market – Future Market Share (%), 2025

Format


Dispatch format is XLSX.

Purchase Checkout Added to cart
face
  • Contact Nick
  •  Email
  •  Contact
  • I was looking for specific epidemiology and utilization data for our emerging therapy situation analysis. It was time sensitive. Your team helped me with the right data and methodologies. Thank you very much.
    - Director, Big Pharma

    About

    • About us
    • Research Store
    • Research Store
    • News
    • Contact

    Trusted By
    Top Companies